.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
AstraZeneca
McKinsey
Dow
US Department of Justice
Mallinckrodt
Covington
McKesson
Chubb

Generated: January 17, 2018

DrugPatentWatch Database Preview

Drug Master Files for: meprobamate

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
441III7/21/1961PRODOTTI CHIMICI DOTTORI REMEPROBAMATE
482III4/26/1962ALFA WASSERMANN SPAMEPROBAMATE
797I5/7/1964VICTOR M HERMELIN CO DIV K-V PHARMACAL COMEPROBAMATE 400MG AND 200MG PROLONGED RELEASE CAPS
877III2/24/1965PHILADELPHIA LABORATORIES INCMANUFACTURING AND CONTROL FOR PRODUCTION OF MEPROBAMATE
898III6/9/1965MILAN PHARMACEUTICALS INCMEPROBAMATE TABLETS
903III8/13/1965WALLACE LABORATORIES DIV CARTER WALLACE INCMEPROBAMATE POWDER-WITH TRACER
1032I2/9/1967MICRO CHEMS LTDMEPROBAMATE N.F.
1089III10/17/1967ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVMEPROBAMATE
1247III10/21/1968KEMKO INCMEPROBAMATE N.F.XII
1552I7/23/1970MILLMASTER CHEM CO DIV MILLMASTER ONYX CORPMEPROBAMATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
Cantor Fitzgerald
McKinsey
Deloitte
Daiichi Sankyo
Moodys
Julphar
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot